Skip to main content

Table 1 Patients’ characteristics

From: Pre-therapeutic lymphocytopenia: a new prognostic factor for failure of endovesical BCG-immunotherapy in non-muscle invasive bladder cancer

Variable

Descriptif N = 200 (%)

Agea

58,95 ± 9,87

Tobacco smoking

135 (90)

Gender

 Male

166 (83)

 Female

34 (17)

Lymphocyte count

 > 1,67 109/L

108 (54)

 ≤ 1,67 109/L

92 (46)

T stage

 PTa

80 (40)

 PT1

120 (60)

Grade

 High grade

131 (34,5)

 Low grade

69(65,5)

 BCG-failure/side effects

81 (40)

 CIS

90 (45)

 Tumor

136 (68)

 Multifocal

64 (32)

 Solitary

59 (29,5)

Size

 > 3 cm

141 (70,5)

 < 3 cm

26(13)

Radical cystoprostatectomy

 Recurrence

80 (40)

 Progression

41 (20)

  1. BCG Calmette-Guerin bacillus, CIS carcinoma in situ, PTa variable grade papillary carcinoma without lamina propria invasion, PT1 variable grade papillary carcinoma with lamina propria invasion but no muscle invasion
  2. a = mean variable expressed + / − standard deviation